Progressive multifocal leukoencephalopathy in the era of chimeric antigen receptor T-cell therapy

Lancet Haematol. 2021 Dec;8(12):e870-e873. doi: 10.1016/S2352-3026(21)00316-1.

Authors

Strachan Mackenzie¹, Arian Laurence¹, Maeve O'Reilly¹, Karl S Peggs², Claire Roddie³

Affiliations

¹ University College London Hospital NHS Foundation Trust, London, UK.
² University College London Hospital NHS Foundation Trust, London, UK; University College London Cancer Institute, London WC1E 6DD, UK.
³ University College London Hospital NHS Foundation Trust, London, UK; University College London Cancer Institute, London WC1E 6DD, UK. Electronic address: c.roddie@ucl.ac.uk.

PMID: 34826407
DOI: 10.1016/S2352-3026(21)00316-1

No abstract available

MeSH terms

Cell- and Tissue-Based Therapy
Humans
Immunotherapy, Adoptive
Leukoencephalopathy, Progressive Multifocal* / therapy
Receptors, Chimeric Antigen*

Substances

Receptors, Chimeric Antigen